Protara Therapeutics to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

Rhea-AI Summary

Protara Therapeutics, Inc. (Nasdaq: TARA) will present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit on September 22, 2021, at 12:25 PM ET. The presentation will be accessible through a webcast on the Company's website and archived for 90 days post-event. Protara focuses on developing transformative therapies for cancer and rare diseases, including its lead program TARA-002 for non-muscle invasive bladder cancer and IV Choline Chloride for intestinal failure-associated liver disease.

NEW YORK, Sept. 17, 2021 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases with significant unmet needs, today announced that management will present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit being held in a virtual setting on Wednesday, September 22, 2021 at 12:25pm ET.

A webcast of the presentation can be accessed by visiting the Events and Presentations section of the Company’s website: https://ir.protaratx.com. The webcast will be archived on the Company’s website for 90 days following the presentation.

About Protara Therapeutics, Inc.

Protara is committed to identifying and advancing transformative therapies for people with cancer and rare diseases with limited treatment options. Protara’s portfolio includes its lead program, TARA-002, an investigational cell-based therapy being developed for the treatment of non-muscle invasive bladder cancer and lymphatic malformations, and IV Choline Chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure-associated liver disease. For more information, visit www.protaratx.com.

Company Contact:

Justine O'Malley
Protara Therapeutics
Justine.OMalley@protaratx.com
646-817-2836

FAQ

When is Protara Therapeutics presenting at the Oppenheimer Summit?

Protara Therapeutics will present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit on September 22, 2021, at 12:25 PM ET.

Where can I watch the Protara Therapeutics presentation?

The presentation will be available via webcast on Protara's website and archived for 90 days.

What is TARA-002?

TARA-002 is an investigational cell-based therapy developed by Protara Therapeutics for treating non-muscle invasive bladder cancer.

What other therapies is Protara Therapeutics developing?

Protara is also developing IV Choline Chloride for intestinal failure-associated liver disease.

How does Protara Therapeutics contribute to rare diseases?

Protara aims to advance therapies for rare diseases that have limited treatment options, focusing on innovative solutions.